{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T03:27:10Z","timestamp":1726457230396},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ahjonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ahj.2016.03.026","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T18:58:30Z","timestamp":1464893910000},"page":"168-175","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial"],"prefix":"10.1016","volume":"178","clinical-trial-number":[{"clinical-trial-number":"nct00091507","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Harry P.","family":"Selker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Rackley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian B.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Ruthazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joni R.","family":"Beshansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Rashba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel H.","family":"Opie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2016.03.026_bb0005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1208200","article-title":"Door-to-balloon time and mortality among patients undergoing primary PCI","volume":"369","author":"Menees","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2016.03.026_bb0010","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2012.426","article-title":"Effect of out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial","volume":"307","author":"Selker","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2016.03.026_bb0015","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.130625","article-title":"Clinician update, glucose-insulin-potassium (GIK): current status of metabolic therapy for acute coronary syndromes and heart failure","volume":"127","author":"Grossman","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.03.026_bb0020","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/253746a0","article-title":"Effects of free fatty acid and enzyme release in experimental glucose on myocardial infarction","volume":"253","author":"De Leiris","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2016.03.026_bb0025","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/2271055a0","article-title":"Effect of fatty acids on contractility and rhythm of the heart","volume":"227","author":"Opie","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2016.03.026_bb0030","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/01.CIR.45.6.1160","article-title":"Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion","volume":"45","author":"Maroko","year":"1972","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.03.026_bb0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jama.293.4.437","article-title":"Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. CREATE-ECLA Trial Group Investigators","volume":"293","author":"Mehta","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ahj.2016.03.026_bb0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ahj.2012.02.002","volume":"163","author":"Selker","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2016.03.026_bb0045","first-page":"103","article-title":"Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure","volume":"6","author":"Gruzdeva","year":"2013","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.ahj.2016.03.026_bb0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0002-9149(62)90035-8","article-title":"Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report","volume":"9","author":"Sodi-Pallares","year":"1962","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2016.03.026_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.CIR.52.1.49","article-title":"Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon","volume":"52","author":"Opie","year":"1975","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.03.026_bb0060","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(09)62001-8","article-title":"Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial","volume":"375","author":"B\u00f8tker","year":"2010","journal-title":"Lancet"},{"issue":"7455","key":"10.1016\/j.ahj.2016.03.026_bb0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(66)92420-2","article-title":"Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion","volume":"2","author":"Kurien","year":"1966","journal-title":"Lancet"},{"issue":"7852","key":"10.1016\/j.ahj.2016.03.026_bb0070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0140-6736(74)92595-1","article-title":"Initial metabolic and hormonal response to acute myocardial infarction","volume":"1","author":"Vetter","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2016.03.026_bb0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-8703(76)80043-9","article-title":"Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion","volume":"92","author":"Rogers","year":"1976","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2016.03.026_bb0080","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0002-9149(85)90720-9","article-title":"Improved myocardial contractility with glucose-insulin-potassium infusion during pacing in coronary artery disease","volume":"55","author":"McDaniel","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2016.03.026_bb0085","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.jacc.2009.07.024","article-title":"The adrenergic-fatty acid load in heart failure","volume":"54","author":"Opie","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.03.026_bb0090","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/01.RES.52.5.515","article-title":"Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion","volume":"52","author":"Apstein","year":"1983","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2016.03.026_bb0095","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1161\/CIRCULATIONAHA.108.780999","article-title":"Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia","volume":"117","author":"Opie","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.03.026_bb0100","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0002-9149(75)90086-7","article-title":"Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size","volume":"36","author":"Opie","year":"1975","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2016.03.026_bb0110","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0735-1097(03)00164-5","article-title":"Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation","volume":"41","author":"Sack","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.03.026_bb0115","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00395-008-0728-x","article-title":"Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion","volume":"103","author":"Fuglesteg","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.ahj.2016.03.026_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2009.03.019","article-title":"Activation of the protective survivor activating factor enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway?","volume":"47","author":"Lecour","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ahj.2016.03.026_bb0125","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.2337\/db13-0420","article-title":"Increased persistent sodium current due to decreased PI3K signaling contributes to QT prolongation in diabetic heart","volume":"62","author":"Lu","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.ahj.2016.03.026_bb0130","series-title":"Heart physiology, from cell to circulation","first-page":"306","author":"Opie","year":"2004"},{"year":"2013","series-title":"Drugs for the heart","author":"Gersh","key":"10.1016\/j.ahj.2016.03.026_bb0135"},{"key":"10.1016\/j.ahj.2016.03.026_bb0140","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1001\/jama.299.20.jlt0528-b","article-title":"Letter. Glucose-insulin-potassium therapy in patients with STEMI. Comment on Mehta et al. (ref. 26)","volume":"299","author":"Opie","year":"2008","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ahj.2016.03.026_bb9000","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1464-5491.2002.00745.x","article-title":"The assessment of insulin resistance in man","volume":"19","author":"Wallace","year":"2002","journal-title":"Diabet Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031630059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031630059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T08:54:46Z","timestamp":1536656086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287031630059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":28,"alternative-id":["S000287031630059X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2016.03.026","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2016.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}